Home / Equities / Equities Analysts Issue Forecasts for Zynerba Pharmaceuticals, Inc.’s Q3 2022 Earnings (NASDAQ:ZYNE)

Equities Analysts Issue Forecasts for Zynerba Pharmaceuticals, Inc.’s Q3 2022 Earnings (NASDAQ:ZYNE)

Analysts at Jefferies Financial Group lifted their Q3 2022 earnings per share estimates for shares of Zynerba Pharmaceuticals in a research note issued to investors on Wednesday, August 10th.
Read Full Story at source (may require registration)